Cancel
Known information
- Previously spent 11 years at Molecular Templates, Inc.
- Served in roles of increasing responsibility before being appointed Chief Development Sciences Officer at Molecular Templates, Inc.
- Led discovery and development efforts for multiple clinical candidates
- Co-invented the Engineered Toxin Body (ETB) platform
- Completed a fellowship in tumor immunology at the National Cancer Institute
- Holds a Ph.D. and M.S from the University of Arkansas
- Holds a B.S. from Texas A&M University
About Immunome
Immunome is a biotechnology company focused on developing innovative cancer therapies, including immunotherapies and targeted treatments, using its proprietary memory B cell hybridoma technology.
Report inaccurate information
